BusinessAbeona Therapeutics Provides Update on EB-101 Gene Therapy for Severe Form of Epidermolysis Bullosa from the Society for Investigative Dermatology ConferenceBy Nasdaq OMXMay 2, 2017, 12:05 PM UTC